Editorial: Chronic rheumatic inflammatory conditions and cardiovascular health.
作者信息
Lo Gullo Alberto, Mandraffino Giuseppe
机构信息
Unit of Rheumatology, Department of Medicine, ARNAS Garibaldi Hospital, Catania, Italy.
Internal Medicine Unit, Department of Clinical and Experimental Medicine, Lipid Center, University of Messina, Messina, Italy.
出版信息
Front Med (Lausanne). 2022 Aug 16;9:953756. doi: 10.3389/fmed.2022.953756. eCollection 2022.
Abstract
摘要
相似文献
1
Editorial: Chronic rheumatic inflammatory conditions and cardiovascular health.
Front Med (Lausanne). 2022 Aug 16;9:953756. doi: 10.3389/fmed.2022.953756. eCollection 2022.
2
Arterial stiffness, the hidden face of cardiovascular risk in autoimmune and chronic inflammatory rheumatic diseases.
Autoimmun Rev. 2021 Sep;20(9):102891. doi: 10.1016/j.autrev.2021.102891. Epub 2021 Jul 3.
3
Pulse wave velocity measurement as a marker of arterial stiffness in pediatric inflammatory bowel disease: a pilot study.
Eur J Pediatr. 2017 Jul;176(7):983-987. doi: 10.1007/s00431-017-2927-7. Epub 2017 May 15.
4
Arterial Stiffness and Adult Onset Vasculitis: A Systematic Review.
Front Med (Lausanne). 2022 May 12;9:824630. doi: 10.3389/fmed.2022.824630. eCollection 2022.
5
Can pulse wave velocity (PWV) alone express arterial stiffness? A neglected tool for vascular function assessment.
J Basic Clin Physiol Pharmacol. 2021 Jul 20;33(4):373-379. doi: 10.1515/jbcpp-2021-0193.
6
Effect of Heart Rate on Arterial Stiffness as Assessed by Pulse Wave Velocity.
Curr Hypertens Rev. 2018;14(2):107-122. doi: 10.2174/1573402113666170724100418.
7
8
Assessing the Impact of Helicobacter pylori Infection and Inflammatory Bowel Disease on Pulse Wave Velocity and Arterial Stiffness.
Cureus. 2021 May 10;13(5):e14944. doi: 10.7759/cureus.14944.
9
Pulse wave velocity is decreased in acromegaly compared to non-acromegaly study participants with similar cardiovascular risk profile.
Growth Horm IGF Res. 2021 Apr-Jun;57-58:101395. doi: 10.1016/j.ghir.2021.101395. Epub 2021 Apr 29.
10
Large artery stiffness according to different assessment methods in adult population of St.Petersburg.
Atheroscler Suppl. 2018 Sep;35:e1-e5. doi: 10.1016/j.atherosclerosissup.2018.08.001. Epub 2018 Aug 24.
本文引用的文献
1
Managing Cardiovascular Risk in Patients with Rheumatic Disease.
Rheum Dis Clin North Am. 2022 May;48(2):429-444. doi: 10.1016/j.rdc.2022.02.003.
2
Mortality in Inflammatory Rheumatic Diseases: Lithuanian National Registry Data and Systematic Review.
Int J Environ Res Public Health. 2021 Nov 24;18(23):12338. doi: 10.3390/ijerph182312338.
3
Speckle tracking echocardiography as a new diagnostic tool for an assessment of cardiovascular disease in rheumatic patients.
Prog Cardiovasc Dis. 2020 May-Jun;63(3):327-340. doi: 10.1016/j.pcad.2020.03.005. Epub 2020 Mar 20.
4
Cardiovascular Event Risk in Rheumatoid Arthritis Compared with Type 2 Diabetes: A 15-year Longitudinal Study.
J Rheumatol. 2020 Mar;47(3):316-324. doi: 10.3899/jrheum.180726. Epub 2019 May 15.
5
EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update.
Ann Rheum Dis. 2017 Jan;76(1):17-28. doi: 10.1136/annrheumdis-2016-209775. Epub 2016 Oct 3.
6
What effects might anti-TNFalpha treatment be expected to have on cardiovascular morbidity and mortality in rheumatoid arthritis? A review of the role of TNFalpha in cardiovascular pathophysiology.
Ann Rheum Dis. 2007 Sep;66(9):1132-6. doi: 10.1136/ard.2006.063867. Epub 2007 Jan 24.
Zotero 插件